Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal Disease
Carmine Zoccali(Biogem), Yūji Matsuzawa(Sumitomo Hospital), Giovanni Tripepi(National Research Council), Pasquale Fatuzzo(University of Catania), Francesca Mallamaci(Società Italiana di Nefrologia), Noriyuki Ouchi(Nagoya University), Sebastiano Cutrupi(National Research Council), Francesco Benedetto(Ospedale Eugenio Morelli), Shinji Kihara(University of Copenhagen), Sachiyo Tanaka(Osaka University), Saverio Parlongo(National Research Council), Michele Buemi(University of Messina), Giuseppe Seminara(University of Catania), Tohru Funahashi(The University of Osaka), Graziella Bonanno(University of Catania), Francesco Rapisarda(University of Catania), Giacomo Nicocia(University of Messina), Lorenzo Malatino(University of Catania)
Cited by 761
Related Papers
Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia
|The Journal of Clinical Endocrinology & Metabolism|2001|3.4k
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
Adiponectin and development of type 2 diabetes in the Pima Indian population
|The Lancet|2002|1.1k